Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Run-In Phase	STARTED	Tasimelteon	57
Run-In Phase	STARTED	Placebo	0
Run-In Phase	Entrained - After Run-In Phase	Tasimelteon	24
Run-In Phase	Entrained - After Run-In Phase	Placebo	0
Run-In Phase	COMPLETED	Tasimelteon	20
Run-In Phase	COMPLETED	Placebo	0
Run-In Phase	NOT COMPLETED	Tasimelteon	37
Run-In Phase	NOT COMPLETED	Placebo	0
Randomized Phase	STARTED	Tasimelteon	10
Randomized Phase	STARTED	Placebo	10
Randomized Phase	COMPLETED	Tasimelteon	10
Randomized Phase	COMPLETED	Placebo	10
Randomized Phase	NOT COMPLETED	Tasimelteon	0
Randomized Phase	NOT COMPLETED	Placebo	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01430754/flow